Lorena Rossi Selected Research

Prostate-Specific Antigen (Semenogelase)

12/2020

Enzalutamide for the treatment of nonmetastatic castration-resistant prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lorena Rossi Research Topics

Disease

11	Prostatic Neoplasms (Prostate Cancer) 12/2020 - 06/2014
10	Neoplasms (Cancer) 01/2023 - 10/2005
3	Colonic Neoplasms (Colon Cancer) 01/2013 - 08/2005
2	Carcinoma (Carcinomatosis) 01/2023 - 01/2021
2	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 12/2018
2	Ovarian Epithelial Carcinoma 01/2021 - 12/2018
2	Neoplasm Metastasis (Metastasis) 12/2020 - 04/2015
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2020 - 10/2016
2	Testicular Neoplasms (Testicular Cancer) 01/2020 - 05/2017
1	Alzheimer Disease (Alzheimer's Disease) 01/2022
1	Dementia (Dementias) 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	Infections 01/2020
1	Kidney Neoplasms (Kidney Cancer) 01/2020
1	Premature Aging 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2018
1	Drug-Related Side Effects and Adverse Reactions 03/2017
1	Frailty 03/2017
1	Stomatitis 10/2016

Drug/Important Bio-Agent (IBA)

6	enzalutamideIBA 12/2020 - 12/2014
4	abirateroneIBA 01/2018 - 06/2014
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 10/2017
3	Hormones (Hormone)IBA 12/2020 - 05/2017
3	Androgen Receptors (Androgen Receptor)IBA 12/2020 - 01/2018
3	Fluorouracil (Carac)FDA LinkGeneric 12/2018 - 08/2005
2	PlatinumIBA 01/2023 - 12/2018
2	Chromogranin AIBA 12/2014 - 06/2014
1	Lipoproteins (Lipoprotein)IBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	Melphalan (Alkeran)FDA LinkGeneric 01/2021
1	Alkylating AgentsIBA 01/2021
1	Prostate-Specific Antigen (Semenogelase)IBA 12/2020
1	AndrogensIBA 12/2020
1	Chimeric Antigen ReceptorsIBA 01/2020
1	NivolumabIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020
1	Cell-Free Nucleic AcidsIBA 11/2019
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2018
1	Leucovorin (Folinic Acid)FDA Link 12/2018
1	Topotecan (Hycamtin)FDA LinkGeneric 12/2018
1	fluoromethylcholineIBA 01/2018
1	RNA (Ribonucleic Acid)IBA 10/2017
1	Vitamin D FDA LinkGeneric 05/2017
1	Everolimus FDA Link 10/2016
1	Hemoglobins (Hemoglobin)IBA 04/2015
1	Docetaxel (Taxotere)FDA Link 06/2014
1	AntimetabolitesIBA 09/2007
1	A-factor (Streptomyces)IBA 09/2007
1	AntigensIBA 10/2005
1	dechromose-A chrommycin A3IBA 10/2005
1	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2005
1	Interferon-gamma (Interferon, gamma)IBA 10/2005
1	Carcinoembryonic AntigenIBA 08/2005
1	Protein Kinase InhibitorsIBA 08/2005
1	StaurosporineIBA 08/2005

Therapy/Procedure

9	Castration 12/2020 - 06/2014
7	Therapeutics 01/2023 - 01/2018
6	Drug Therapy (Chemotherapy) 01/2020 - 01/2013
2	Immunotherapy 01/2020 - 12/2017
1	Salvage Therapy 01/2023
1	Cognitive Training 01/2022
1	Aftercare (After-Treatment) 01/2021
1	Self-Help Devices (Assistive Technology) 01/2021
1	Hematopoietic Stem Cell Transplantation 01/2020
1	Polypharmacy 03/2017
1	Drug Tapering 10/2016
1	Adjuvant Chemotherapy 01/2013